Login

Metro Systems Corporation PCL (MSC TB) is a world-class technology company. 00:10:00

Share On Facebook Share On Twitter

Tavit Charuvajana is CEO/Exec Dir at Metro Systems Corp PCL

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Disaster Planning Webinar: Essential Steps for Natural Disaster Preparedness | Derek Hensley - Wealth Advisor of Sound Stewardship, LLC
00:10:00
Adapting to Real Estate's New Normal: Trends in Leasing and Market Predictability | Christian Ulbrich, CEO, JILL GLOBAL.
00:10:00
Biomarker testing could dramatically improve patient health outcomes|Francois Desjardins,Vice President,Bellus Health
00:10:00
Invests in companies that transforms the quality of living for aging consumers|Alan Patricof,Chairperson,Primetime Partners
00:10:00
From Music to Startups to Venture|Alex Pall, Partner,MANTIS Venture Capital
00:10:00
Sarah Ketterer: Leading Causeway Capital with Strategic Portfolio Management
00:10:00
Invests in companies with proven solutions|Jason Palmer,General Partner,New Markets Venture Partners
00:10:00
"Meet the Manager: Shane Hurst on Navigating Global Trends in Infrastructure Investment" | Shane Hurst - Managing Director and Portfolio Manager of the Legg Mason
00:10:00
Institutions who provide the FUEL for our FOCUS on helping disruptive founders|Maggie Vo,Managing General Partner and Chief Investment Officer,Fuel Venture Capital
00:10:00
What makes a Great Founder|Magnus Grimeland,Founder and CEO,Antler
00:10:00
Provides investable assets for diverse angel investors to fund tomorrow's companies|Theresia Gouw,Founding Partner,Acrew Capital
00:10:00
Key Role of Carbon Footprint Allocation in Poland's Energy Sector Transformation | Paweł Majewski, CEO, Enea SA.

© 2026 Nehu